5-Fluorouracil (5-FU) continuous intravenous infusion compared with bolus administration. Final results of a randomised trial in metastatic colorectal cancer

scientific article published on 01 October 1997

5-Fluorouracil (5-FU) continuous intravenous infusion compared with bolus administration. Final results of a randomised trial in metastatic colorectal cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0959-8049(97)00175-5
P698PubMed publication ID9470834

P2093author name stringC Rekacewicz
J Jacob
F Morvan
P Rougier
M Ducreux
J F Seitz
J M Tigaud
B Paillot
A LaPlanche
M C Fabri
M Luboinski
P Laplaige
S Grandjouan
P2860cites workDesign and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examplesQ24569561
Nonparametric Estimation from Incomplete ObservationsQ25938997
Reporting results of cancer treatmentQ29620070
Comparison of continuously infused 5-fluorouracil with bolus injection in treatment of patients with colorectal adenocarcinomaQ34523575
Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinomaQ38207042
Estimation of confidence limits for the cumulative probability of survival in life table analysisQ41897761
A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program StudyQ44583571
Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group studyQ44664927
Systemic infusion versus bolus chemotherapy with 5-fluorouracil in measurable metastatic colorectal cancerQ67591718
Phase II trial of 7-day continuous 5-fluorouracil infusion in the treatment of advanced colorectal carcinomaQ68066794
Time-schedule dependency of the inhibiting activity of various anticancer drugs in the clonogenic assayQ70058382
Chronomodulated versus fixed-infusion-rate delivery of ambulatory chemotherapy with oxaliplatin, fluorouracil, and folinic acid (leucovorin) in patients with colorectal cancer metastases: a randomized multi-institutional trialQ72732640
P433issue11
P921main subjectcolorectal cancerQ188874
fluorouracilQ238512
colorectal carcinomaQ25493920
metastatic colon cancerQ108566365
P304page(s)1789-1793
P577publication date1997-10-01
P1433published inEuropean Journal of CancerQ332260
P1476title5-Fluorouracil (5-FU) continuous intravenous infusion compared with bolus administration. Final results of a randomised trial in metastatic colorectal cancer
P478volume33

Reverse relations

cites work (P2860)
Q73898297Effect of carbogen breathing on the pharmacodynamics of 5-fluorouracil in a murine colon carcinoma
Q38081864Management of advanced colorectal cancer, Part 1.
Q39392750MicroRNA-101 (miR-101) post-transcriptionally regulates the expression of EP4 receptor in colon cancers
Q36178667Pre-operative radiochemotherapy of locally advanced rectal cancer
Q44146804Preoperative chemoradiation using oral capecitabine in locally advanced rectal cancer
Q35579304Radiotherapy and Oral Capecitabine in the Preoperative Treatment of Patients with Rectal Cancer: Rationale, Preliminary Results and Perspectives
Q77632445Rational development of capecitabine
Q26830695Systemic treatment-induced gastrointestinal toxicity: incidence, clinical presentation and management
Q34928276The novel highly lipophilic topoisomerase I inhibitor DB67 is effective in the treatment of liver metastases of murine CT-26 colon carcinoma.
Q34711507Which endpoints should we use in evaluating the use of novel fluoropyrimidine regimens in colorectal cancer?

Search more.